Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice

Behavioural Brain Research

Volumn 235, Issue 1, 2012, Pages 67-72

  Zhang, Lin ^a   Xu, Tianyuan ^a   Wang, Shuang ^a   Yu, Lanqing ^a   Liu, Dexiang ^a   Zhan, Renzhi ^a,b   Yu, Shu Yan ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Provincial Key Laboratory of Mental Disorders   (China)

Author keywords

Amygdala; BDNF; Curcumin; ERK1 2; Forced swim test

Indexed keywords

ALPHA [AMINO(4 AMINOPHENYLTHIO)METHYLENE] 2 (TRIFLUOROMETHYL)PHENYLACETONITRILE; BRAIN DERIVED NEUROTROPHIC FACTOR; CURCUMIN; FLUOXETINE; MITOGEN ACTIVATED PROTEIN KINASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FORCED SWIMMING TEST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINOACETONITRILE; AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CURCUMIN; DEPRESSION; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; PHOSPHORYLATION;

EID: 84864761504     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.07.019     Document Type: Article

References (30)

1. Ereshefsky L. Drug-drug interactions with the use of psychotropic medications: questions and answers. CNS Spectrums 2009, 14(8):1-8.
2. Van der Watt G., Laugharne J., Janca A. Complementary and alternative medicine in the treatment of anxiety and depression. Current Opinion in Psychiatry 2008, 21(1):37-42.
3. Maheshwari R.K., Singh A.K., Gaddipati J., Smiral R.C. Multiple biological activities of curcumin: a short review. Life Sciences 2006, 78:2081-2087.
4. Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. International Journal of Biochemistry and Cell Biology 2009, 41:40-59.
5. Kulkarni S., Dhir A., Akula K.K. Potentials of curcumin as an antidepressant. Scientific World Journal 2009, 9:1233-1241.
6. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., et al. The effects of curcumin on depressive-like behaviors in mice. European Journal of Pharmacology 2005, 518:40-46.
7. Xu Y., Ku B.S., Yao H.Y., Lin Y.H., Ma X., Zhang Y.H., et al. Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats. Pharmacology Biochemistry and Behavior 2005, 82:200-206.
8. Kulkarni S.K., Bhutani M.K., Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology (Berl) 2008, 201:435-442.
9. Wang R., Xu Y., Wu H.L., Li Y.B., Li Y.H., Guo J.B., et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. European Journal of Pharmacology 2008, 578:43-50.
10. Lin T.Y., Lu C.W., Wang C.C., Wang Y.C., Wang S.J. Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011, 35(7):1785-1793.
11. Zhou H., Beevers C.S., Huang S. The targets of curcumin. Current Drug Targets 2011, 12:332-347.
12. Tanis K.Q., Duman R.S. Intracellular signaling pathways pave roads to recovery for mood disorders. Annals of Medicine 2007, 39:531-544.
13. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annual Review of Neuroscience 2001, 24:677-736.
14. Castren E., Voikar V., Rantamaki T. Role of neurotrophic factors in depression. Current Opinion in Pharmacology 2007, 7(1):18-21.
15. Karege F., Perret H., Bondolfi G., Schwald M., Bertschy G., Aubrey J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research 2002, 109:143-148.
16. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 1995, 15:7539-7547.
17. Muller S., Chakrapani B.P., Schwegler H., Hofmann H.D., Kirsch M. Neurogenesis in the dentate gyrus depends on ciliary neurotrophic factor and signal transducer and activator of transcription 3 signaling. Stem Cells 2009, 27:431-441.
18. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Gabriela Nielsen M., Placentino A., et al. Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World Journal of Biological Psychiatry 2010, 11:763-773.
19. Xu Y., Ku B., Cui L., Li X., Barish P.A., Foster T.C., et al. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Research 2007, 1162:9-18.
20. Xu Y., Ku B., Tie L., Yao H., Jiang W., Ma X., et al. Curcumin reverses the effects of chronic stress on behavior, the HPA axis, BDNF expression and phosphorylation of CREB. Brain Research 2006, 1122(1):56-64.
21. Wang R., Li Y.H., Xu Y., Li Y.B., Wu H.L., Guo H., et al. Curcumin produces neuroprotective effects via activating brain-derived neurotrophic factor/TrkB-dependent MAPK and PI-3K cascades in rodent cortical neurons. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2010, 34(1):147-153.
22. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Groll C., Jäger M., et al. Hippocampal changes in patients with a first episode of major depression. American Journal of Psychiatry 2002, 159:1112-1118.
23. Kumar A., Dogra S., Prakash A. Protective effect of curcumin (Curcuma longa), against aluminium toxicity: possible behavioral and biochemical alterations in rats. Behavioural Brain Research 2009, 205(2):384-390.
24. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
25. Bhutani M.K., Bishnoi M., Kulkarni S.K. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacology Biochemistry and Behavior 2009, 92(1):39-43.
26. Cyrna J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews 2005, 29(4-5):547-569.
27. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nature Reviews Neuroscience 2006, 7:137-151.
28. Henkel A.W., Sperling W., Rotter A., Reulbach U., Reichardt C., Bönsch D., et al. Antidepressant drugs modulate growth factors in cultured cells. BMC Pharmacology 2008, 8:6.
29. Sweatt J.D. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. Journal of Neurochemistry 2001, 76(1):1-10.
30. Tao X., Finkbeiner S., Arnold D.B., Shaywitz A.J., Greenberg M.E. Calcium influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 1997, 20:709-726.